China SXT Pharmaceuticals Stock Scheduled to Reverse Split on Tuesday, February 25th (NASDAQ:SXTC)

Shares of China SXT Pharmaceuticals, Inc. (NASDAQ:SXTCFree Report) are scheduled to reverse split on Tuesday, February 25th. The 1-8 reverse split was announced on Friday, February 21st. The number of shares owned by shareholders will be adjusted after the market closes on Monday, February 24th.

China SXT Pharmaceuticals Trading Down 8.7 %

Shares of SXTC traded down $0.03 during midday trading on Friday, hitting $0.34. The stock had a trading volume of 1,544,507 shares, compared to its average volume of 439,662. The stock’s 50 day moving average is $0.41 and its 200 day moving average is $0.55. China SXT Pharmaceuticals has a 1 year low of $0.30 and a 1 year high of $3.37.

China SXT Pharmaceuticals Company Profile

(Get Free Report)

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read More

Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.